FDA Allows Marketing of First Direct-to-Consumer App for Contraceptive Use to Prevent Pregnancy

FDAThe U.S. Food and Drug Administration permitted marketing of the first mobile medical application (app) that can be used as a method of contraception to prevent pregnancy. The app, called Natural Cycles, contains an algorithm that calculates the days of the month a woman is likely to be fertile based on daily body temperature readings and menstrual cycle information, a method of contraception called fertility awareness. Designed for mobile devices, it is intended for use in pre-menopausal women aged 18 and older.

Natural Cycles requires women to take their temperature daily using a basal body thermometer, in the morning immediately upon waking, and to enter the reading into the app, which also tracks a user’s menstrual cycle. Basal body thermometers are more sensitive than regular thermometers and detect a minor rise in temperature, only about half of one degree Fahrenheit, around the time of ovulation. Women using the app for contraception should abstain from sex or use protection (such as a condom) when they see "use protection" displayed on the app, which means they're more likely to be fertile during those days.

"Consumers are increasingly using digital health technologies to inform their everyday health decisions, and this new app can provide an effective method of contraception if it's used carefully and correctly," said Terri Cornelison, M.D., Ph.D., assistant director for the health of women in the FDA's Center for Devices and Radiological Health. "But women should know that no form of contraception works perfectly, so an unplanned pregnancy could still result from correct usage of this device."

Clinical studies to evaluate the effectiveness of Natural Cycles for use in contraception involved 15,570 women who used the app for an average of eight months. The app had a "perfect use" failure rate of 1.8 percent, which means 1.8 in 100 women who use the app for one year will become pregnant because they had sexual intercourse on a day when the app predicted they would not be fertile or because their contraceptive method failed when they had intercourse on a fertile day. The app had a "typical use" failure rate of 6.5 percent, which accounted for women sometimes not using the app correctly by, for example, having unprotected intercourse on fertile days.

Natural Cycles should not be used by women who have a medical condition where pregnancy would be associated with a significant risk to the mother or the fetus or those currently using birth control or hormonal treatments that inhibit ovulation. Natural Cycles does not provide protection against sexually transmitted infections.

The FDA reviewed the Natural Cycles app through the de novo premarket review pathway, a regulatory pathway for novel, low-to-moderate-risk devices of a new type. Along with this authorization, the FDA is establishing criteria, called special controls, which clarify the agency’s expectations in assuring the accuracy, reliability and effectiveness in preventing pregnancy using apps indicated for contraception. These special controls, when met along with general controls, provide a reasonable assurance of safety and effectiveness for apps used for contraception. This action also creates a new regulatory classification, which means that subsequent devices with the same intended use may go through the FDA's 510(k) process, whereby devices can obtain marketing authorization by demonstrating substantial equivalence to a predicate device.

Last year, the FDA released a Digital Health Innovation Action Plan to look at ways to provide clarity and find efficiency in how the agency regulates digital health technologies like the Natural Cycles app.

The FDA granted the marketing authorization for this app to Natural Cycles Nordic AB.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Most Popular Now

Alcon to Develop SMART Suite Digital Hea…

Alcon, the global leader in eye care and a division of Novartis, today announced plans to develop the SMART Suite by Alcon, an innovative, digital platform that is designed to...

Philips Launches First Global Start-Up C…

Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced the launch of its first global start-up collaboration program involving Philips' innovation hubs in Cambridge (US), Eindhoven...

Simple Stickers may Save Lives of Patien…

Heart surgery can be traumatic for patients. Having to continuously monitor your status without a doctor when you are back home can be even scarier. Imagine being able to do...

Digital Health Consultancy Expands to Su…

Digital health consultancy Populo Consulting has announced the appointment of a new managing director as part of an ambitious growth strategy. The expansion will enable it to support more NHS...

MEDICA 2018 Boasts over 5,000 Exhibitors…

12 - 15 November 2018, Düsseldorf, Germany. When top decision-makers in the healthcare business meet in Düsseldorf in the middle of November at the world's leading medical trade fair, MEDICA 2018...

Stanford, Apple Describe Heart Study wit…

A clinical trial to determine whether a smartwatch app that analyzes pulse-rate data can screen for a heart-rhythm disorder has enrolled more than 400,000 participants. Researchers at Stanford Medicine, in...

With Mobilett Elara Max, Siemens Healthi…

With the presentation of Mobilett Elara Max, Siemens Healthineers is setting new standards in mobile X-ray imaging. The easy-to-clean system surfaces with an antimicrobial coating reduce the risk of hospital...

Augmented Reality may Assist Cardiologis…

Augmented reality (AR), a technology that superimposes computer-generated information on a user's view of the real world, offers a new platform to help physicians better visualize complex medical data, particularly...

The Partnership for Digital Healthis Com…

15 - 16 November 2018, Berlin, Germany. The initiative co-founded by Egon Zehnder and including partners Sanofi, SAP and Qiagen, is one of the most forward-thinking partnerships for promoting innovation in...

Health Tech Communications Agency Takes …

Highland Marketing, a full service marketing communications agency for the health tech and wider public sector markets, has appointed Michelle Cheng as marketing executive to support the business' rapid growth.

IBM to Acquire Red Hat, Completely Chang…

IBM (NYSE:IBM) and Red Hat (NYSE:RHT), the world's leading provider of open source cloud software, announced that the companies have reached a definitive agreement under which IBM will acquire all...